期刊文献+

确认药物靶点的蛋白质相互作用技术及方法

Protein-protein interaction technologies and methods for drug target identification
下载PDF
导出
摘要 蛋白相互作用(protein-protein interactions,PPI)在细胞生长发育、新陈代谢及衰老凋亡中发挥重要作用,PPI异常可导致多种疾病的发生。发展新技术尤其是PPI技术,在分子水平上揭示特定蛋白的功能及其与化学小分子的作用,能准确找到化学小分子的作用靶点,有助于疾病的诊断和治疗。本文综述近年来PPI技术在药物靶点确认中的研究进展。 Protein-protein interactions(PPI)play an indispensable role in cell growth,metabolism,aging and apoptosis.Abnormal PPI will lead to cell dysfunction and diseases. Thus,it is necessary to build new technologies for target identification. PPI technologies can reveal the function of proteins and the interaction of proteins with the other molecules at molecular level,so they are widely used in identification of drug target. In this review,applications of PPI technologies in drug target identification are introduced.
出处 《国际药学研究杂志》 CAS CSCD 2014年第5期542-547,共6页 Journal of International Pharmaceutical Research
关键词 蛋白质相互作用 方法学 技术 药物靶点 药物研发 protein-protein interaction methodology technology drug target drug development
  • 相关文献

参考文献2

二级参考文献72

  • 1Hopkins A L. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol, 2008, 4:682-690.
  • 2Barabasi A L, Oltvai Z N. Network biology: Understanding the cell's functional organization. Nat Rev Genet, 2004, 5:101-113.
  • 3Goh K I, Cusick M E, Valle D, et al. The human disease network. Proc Natl Acad Sci USA, 2007, 104:8685-8690.
  • 4Wu X, Jiang R, Zhang M Q, et al. Network-based global inference of human disease genes. Mol Syst Biol, 2008, 4:189.
  • 5Feldman I, Rzhetsky A, Vitkup D. Network properties of genes har- boring inherited disease mutations. Proc Natl Acad Sci USA, 2008, 105:4323-4328.
  • 6Kitano H. A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov, 2007, 6:202-210.
  • 7Chen Y, Zhu J, Lum P Y, et al. Variations in DNA elucidate molecular networks that cause disease. Nature, 2008, 452:429-435.
  • 8Korcsmaros T, Szalay M S, Bode C, et al. How to design multi-target drugs: Target search options in cellular networks. Expe Opin Drug Discov, 2007, 2:1-10.
  • 9Paolini G V, Shapland R H, van Hoorn W P, et al. Global mapping of pharmacological space. Nat Biotechnol, 2006, 24:805-815.
  • 10Grimaldi D, Claessens Y E, Mira J P, et al. Beyond clinical phenotype: The biologic integratome. Cfit Care Med, 2009, 37(1 Suppl): S38-S49.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部